A STABILIZED FORMULATION OF FESOTERODINE
The present invention relates to a stable pharmaceutical formulation, containing fesoterodine [2-[(1R)-3-(Di(propan-2-yl)amino)-1-phenylpropyl]-4- (hydroxymethyl)phenyl] 2-methyl propanoate of formula (I) and/or its salts, solvate ester and a method of its preparation. (Formula (I))